ATS 2024 Final Program

Click on the session title to view the speakers

SUNDAY • MAY 19

99

• learners will increase clinical knowledge of management and treatment approaches of pathologies presented Pulmonary fellows or medical residents present interesting cases to a multidisciplinary panel of master clinicians to demonstrate a team approach to diagnosing and managing challenging clinical cases. The session will shed light on both common and rare pathologies in pulmonary and critical care medicine enhancing medical knowledge, diagnostic and management skills.

Combined pulmonary fibrosis and emphysema (CPFE) is a clinical entity that is not well defined as discussed in the ATS/ERS/JRS/ALAT Research Statement published in 2022. This session is well suited for both clinicians and researchers who want to gain a deeper understanding into the pathogenesis and biologic mechanisms behind the development of fibrosis and emphysema, key radiologic signatures of disease and available therapeutic options for CPFE patients. This knowledge base will help us define critical research priorities, the crucial next step given the known poor outcomes in this patient population who unfortunately have an underdiagnosed and understudied disease. 2:15 Patient Speaker 2:20 Combined Pulmonary Fibrosis and Emphysema: What We Know and Need to Know 2:25 Diagnostic Categorization of Combined Pulmonary Fibrosis and Emphysema 2:35 Questions for Dr. Vincent Cottin 2:39 Biological Implications and Pathways of Fibrosis and Emphysema Development 2:49 Questions for Dr. Timothy Blackwell 2:53 Clinical Manifestations of the Syndrome of Combined Pulmonary Fibrosis and Emphysema 3:03 Questions for Dr. Tamera Corte 3:07 Imaging Features in Combined Pulmonary Fibrosis and Emphysema and Quantifying Disease Severity 3:17 Questions for Dr. Rachel Putnam 3:21 Therapeutic Options for Patients with Combined Pulmonary Fibrosis and Emphysema 3:31 Questions for Dr. Sara Tomassetti 3:35 Panel Discussion This session and the International Conference are supported

2:15 Knew You Were Trouble 2:27 Everything Has Changed 2:39 Anti-Hero 2:51 Pediatric Case: Cruel Summer 3:03 Master Clinician

Master Pathologist Master Radiologist

CLINICAL • TRANSLATIONAL CLINICAL TOPICS IN PULMONARY MEDICINE A84 COMBINED PULMONARY FIBROSIS AND EMPHYSEMA: FROM PATHOGENESIS TO DIAGNOSIS AND THERAPEUTIC IMPLICATIONS Assembly on Clinical Problems 2:15 p.m. - 3:45 p.m. Marriott Marquis San Diego Marina Grand Ballroom 8-9 (Lobby Level, North Tower) Target Audience Providers who see patients with chronic obstructive pulmonary disease (COPD) and/or interstitial lung disease (ILD) and researchers with a basic or clinical research background in COPD and/or ILDs Objectives At the conclusion of this session, the participant will be able to: • define new strategies to manage the care of patients with combined pulmonary fibrosis and emphysema in order to improve their quality of life and symptom burden • better diagnose patients with combined pulmonary fibrosis and emphysema • integrate/incorporate new guidelines from the official 2022 ATS research statement on CPFE into current practice

by an independent medical educational grant from Boehringer IngelheimPharmaceuticals, Inc.

All CMEsessions have been planned and implemented in accordancewith the AccreditationCriteria of theAccreditationCouncil for ContinuingMedical Education (ACCME ® ) and are free of the control of ineligible companies (formerly commercial interests).

ATS 2024 Conference Program • San Diego, CA